Arnaud Attyé1,2, Felix Renard3, Monica Baciu2, Elise Roger2, Laurent Lamalle4, Patrick Dehail5, Hélène Cassoudesalle5, and Fernando Calamante6,7
1School of Biomedical Engineering, University of Sydney, Sydney, Australia, 2CNRS LPNC UMR 5105, University of Grenoble Alpes, Grenoble, France, 3Laboratoire d'informatique de Grenoble, Grenoble, France, 4University of Grenoble Alpes, Grenoble, France, 5Bordeaux Universitary Hospital, Bordeaux, France, 6Sydney Imaging Lab, University of Sydney, Sydney, Australia, 7School of Aerospace, Mechanical and Mechatronic Engineering, Sydney, Australia
Synopsis
Here we present a unified framework for brain
fascicles quantitative analyses by geodesic learning (TractLearn) — as a data-driven
unsupervised learning task. TractLearn
allows a mapping between the image high-dimensional domain and the reduced
latent space of brain fascicles. Besides providing a framework to test the
reliability of various brain metrics with a global overview, it allows to identify
subtle quantitative alteration in disease model with small subset of patients
and/or data sparsity.
With this regard, TractLearn is a ready-to-use algorithm
for precision medicine.
Introduction
Streamlines from diffusion-weighted imaging
(DWI) provide a wealth of information regarding brain structural connectivity.
A deep-learning approach was recently proposed to generate major brain
fascicles from fiber orientation distribution (FOD) function peaks [1]. The information contained
in these local tractograms can be subsequently exploited to generate maps with
different contrasts using the track-weighted imaging (TWI) framework [2].
However, statistical analyses on all
quantitative values contained in each fascicle is difficult owing to the curse
of dimensionality. In addition, classical voxel-based analysis doesn’t consider
the global interaction between voxel modification in a dedicated bundle.
Here, we propose a 3-step method to obtain a
fast-quantitative analysis of all brain bundles, through their TWI contrast.
Firstly, we will reduce the dimensionality of
all voxels contained in each bundle, to have one point per bundle and
individual in a manifold subspace. Secondly, we will learn the manifold [3,4] from our healthy controls
first dataset and project onto the second retest dataset to check the reliability.
Finally, we propose to mathematically detect abnormalities in a trauma model by
applying Z-scores to the projection of a new subject onto the same manifold.METHODS
20 healthy males (age=20.9±3.3) were scanned on
a 3T Siemens Prisma scanner: high-angular resolution, multi-shell DWI acquired
for each subject over two sessions (12 months apart). 5 patients referred with mild traumatic brain injury were also included with the same protocol.
Preprocessing included denoising [5], eddy current and motion
correction [6], bias field and Gibbs
artifacts’ corrections [7], and up-sampling to 1 mm3
[8]. FODs were computed using Spherical
Deconvolution [9] in
MRtrix3 (www.mrtrix.org). TractSeg (https://github.com/MIC-DKFZ/TractSeg) used pre-trained DWI data to reconstruct 72 discrete
bundles [1]. For
each bundle, we calculated the mean TW-FOD, which was computed using the FODs in
the TWI framework [2]).
Modeling brain
fascicles with TractLearn
We use the strategy developed in [4, 10] to localize an anomaly among
TractSeg fascicles, which can be summarized as follow:
1/Dimensionality reduction to convert collection
of voxels quantitative values from each bundle into a unique point in a
manifold subspace. Here we have used U-map
[11].
2/ We built an atlas based on healthy controls
dataset: Y=f(x)+epsilon. Y
being healthy control data in real space (ie. TWI values extracted from each bundle), x the corresponding point in the reduced space and epsilon the residuals. f will be the regression equation
between the reduced space and the natural space.
To ensure robustness, epsilon was estimated using a leave-one-out strategy.
3/ Any new subject (retest or mTBI patient) will
be "projected" onto the learned manifold representing the normal controls. The
projection f will correspond to the
image closest to that of the tested subject, while belonging to the normal
controls manifold.
We consider that the residual epsilon is representative of any abnormalities present in a new
subject when it is greater than the model variability learned during the
leave-one-out on controls.
A bootstrap method was applied to estimate the
uncertainty of the distance distribution, by randomly selecting inter and
intra-individual distance in the manifold. We finally identified altered voxels
in each fascicle by applying a Z-Score, with threshold corresponding to p<0.01 (Figure 1).RESULTS
69 of 72 brain bundles were
successfully-reconstructed in all subject using TractSeg.
We have then extracted voxel values from 69
tract masks in all subject to project in the manifold subspace (Figure 2).
Using TractLearn,
the distance in the geodesic space for one bundle was significantly shorter
between the test and the retest procedure (same subject) than between two
different subjects (p<0.001) (Figure 3).
In the mTBI cohort, we have identified
significantly altered Z-Score in 3 out of 5 subjects. Subjects 1 and 2
presented voxels alterations in Corpus Callosum sub-divisions 1 (CC1), CC2 and
CC5 for the former (figure 4); CC2 and CC3 for the latter. Subject 5 presented alterations
in left corticospinal tract (p<0.01).DISCUSSION
TractLearn demonstrates high
test-retest values, and allowed detecting white matter abnormalities in the
corpus callosum of 2 mTBI subjects, and in the corticospinal tract of a further
patient. The injuries location are compatible with the known pathophysiology of
mTBI [12, 13].
In addition, we propose a new statistical test
for the evaluation of a collection of biomarkers extracted from brain bundles,
here employed to demonstrate the reliability of both TractSeg and the track-weighted contrast of each fascicle over
time.
The demonstration relies on the vicinity of each manifold point (ie. Test
and Retest points) using a bootstrap method. TWI has proved to be powerful in mapping
fascicles alterations in neurodegenerative diseases [14, 15] or mild traumatic brain
injury (mTBI) preclinical imaging [16] to cite a few. Yet other DWI
markers could be also tested with the same framework as it only needs a
collection of quantitative metrics as input.
U-map [11] has been developed
to merge the visualization power of t-SNE algorithm
[3] with more respect to the global structure, in our case the brain white matter
bundle voxels.
We also propose a generalization of the
classical z-score where f(x)
corresponds to the mean value. We have modeled the population by a regression
function instead of a unique sample [4].Acknowledgements
The Grenoble MRI facility IRMaGe was partly funded by the French program
“Investissement d’Avenir” run by the “Agence nationale pour la recherche” (grant
number: ANR-11-INBS-0006).References
1.Wasserthal
J, Neher P, Maier-Hein KH (2018) TractSeg - Fast and accurate white matter
tract segmentation. NeuroImage 183:239–253.
https://doi.org/10.1016/j.neuroimage.2018.07.070
2.Calamante
F (2017) Track-weighted imaging methods: extracting information from a
streamlines tractogram. Magma N Y N. https://doi.org/10.1007/s10334-017-0608-1
3.Tenenbaum
JB, de Silva V, Langford JC (2000) A global geometric framework for nonlinear
dimensionality reduction. Science 290:2319–2323.
https://doi.org/10.1126/science.290.5500.2319
4.Tilquin
F, Faisan S, Heitz F, et al (2019) Anomaly Detection in Single Subject vs Group
Using Manifold Learning. In: ICASSP 2019 - 2019 IEEE International Conference
on Acoustics, Speech and Signal Processing (ICASSP). pp 2867–2871
5.Veraart
J, Novikov DS, Christiaens D, et al (2016) Denoising of diffusion MRI using
random matrix theory. NeuroImage 142:394–406.
https://doi.org/10.1016/j.neuroimage.2016.08.016
6.Andersson
JLR, Skare S, Ashburner J (2003) How to correct susceptibility distortions in
spin-echo echo-planar images: application to diffusion tensor imaging.
NeuroImage 20:870–888. https://doi.org/10.1016/S1053-8119(03)00336-7
7.Tustison
NJ, Avants BB, Cook PA, et al (2010) N4ITK: improved N3 bias correction. IEEE
Trans Med Imaging 29:1310–1320. https://doi.org/10.1109/TMI.2010.2046908
8.Raffelt
D, Tournier J-D, Crozier S, et al (2012) Reorientation of fiber orientation
distributions using apodized point spread functions. Magn Reson Med 67:844–855.
https://doi.org/10.1002/mrm.23058
9.Jeurissen
B, Tournier J-D, Dhollander T, et al (2014) Multi-tissue constrained spherical
deconvolution for improved analysis of multi-shell diffusion MRI data. NeuroImage
103:411–426. https://doi.org/10.1016/j.neuroimage.2014.07.061
10.Vik T,
Heitz F, Charbonnier P (2007) Robust pose estimation and recognition using
non-gaussian modeling of appearance subspaces. IEEE Trans Pattern Anal Mach
Intell 29:901–905. https://doi.org/10.1109/TPAMI.2007.1028
11.McInnes
L, Healy J, Melville J (2018) UMAP: Uniform Manifold Approximation and
Projection for Dimension Reduction. ArXiv180203426 Cs Stat
12.Delouche
A, Attyé A, Heck O, et al (2016) Diffusion MRI: Pitfalls, literature review and
future directions of research in mild traumatic brain injury. Eur J Radiol
85:25–30. https://doi.org/10.1016/j.ejrad.2015.11.004
13.Stokum
JA, Sours C, Zhuo J, et al (2015) A longitudinal evaluation of diffusion
kurtosis imaging in patients with mild traumatic brain injury. Brain Inj 29:47–57.
https://doi.org/10.3109/02699052.2014.947628
14.Bozzali
M, Parker GJM, Serra L, et al (2011) Anatomical connectivity mapping: a new
tool to assess brain disconnection in Alzheimer’s disease. NeuroImage 54:2045–2051.
https://doi.org/10.1016/j.neuroimage.2010.08.069
15.Ziegler
E, Rouillard M, André E, et al (2014) Mapping track density changes in
nigrostriatal and extranigral pathways in Parkinson’s disease. NeuroImage
99:498–508. https://doi.org/10.1016/j.neuroimage.2014.06.033
16.Tan XL,
Wright DK, Liu S, et al (2016) Sodium selenate, a protein phosphatase 2A
activator, mitigates hyperphosphorylated tau and improves repeated mild
traumatic brain injury outcomes. Neuropharmacology
108:382–393. https://doi.org/10.1016/j.neuropharm.2016.05.001